Literature DB >> 32168367

Correction: Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017.

Lingyan Yu, Kai Ding, Lifang Luo, Zhenwei Yu.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0227595.].

Entities:  

Year:  2020        PMID: 32168367      PMCID: PMC7069635          DOI: 10.1371/journal.pone.0230694

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There are a number of errors in the Year and Age values of Table 1. Please see the correct Table 1 here.
Table 1

The population demographic characteristics of included prescriptions from 2013 to 2017.

Year20132014201520162017
Age
18–391076 (7.79)1196 (7.87)1263 (7.90)1648 (8.57)1694 (8.44)
40–491134 (8.21)1197 (7.88)1304 (8.15)1604(8.34)1794 (8.94)
50–592324 (16.83)2463 (16.20)2439 (15.25)3035 (15.78)3139 (15.65)
60–693775 (27.34)4156 (27.34)4557(28.49)5524 (28.72)5828 (29.05)
70 up5499 (39.82)6188 (40.71)6434 (40.22)7421 (38.59)7605 (37.91)
Sex
Male8900 (46.12)9677 (46.67)9856 (45.85)12408 (46.39)12894 (45.84)
Female10397 (53.88)11057 (53.33)11642 (54.15)14342 (53.61)15237 (54.16)
Data are represented as number of patients (%).
  1 in total

1.  Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017.

Authors:  Lingyan Yu; Kai Ding; Lifang Luo; Zhenwei Yu
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

  1 in total
  1 in total

1.  Anti-seizure Medication Prescription in Adult Outpatients With Epilepsy in China, 2013-2018.

Authors:  Lingyan Yu; Wenjie Zhu; Xiuping Zhu; Yan Lu; Zhenwei Yu; Haibin Dai
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.